TOP HEADLINES

Featured Story

GE Healthcare says strong U.S. growth offset weakness abroad

GE touted the strength of its healthcare business in the U.S., saying the country compensates for slowing growth in countries like Japan and Russia and is a headwind against unfavorable exchange rates abroad.

bioMérieux and Astute Medical join forces on acute kidney injury test

French in vitro diagnostics outfit bioMérieux and Astute Medical are teaming up to develop Astute's test for acute kidney injury, continuing the companies' recent diagnostics winning streak and helping them capitalize on a growing market.

FDA approves next-gen Medtronic device to treat drug-refractory gastroparesis

The FDA has approved a second-generation Medtronic device to treat gastroparesis patients who are not able to control nausea and vomiting using drugs. The Enterra II System has been approved under a humanitarian device exemption, which is used by the agency to approve devices intended for a population of fewer than 4,000 people in the U.S.

Plaintiffs' lawyers dismiss J&J's latest claim as vaginal mesh litigation drags on

In the latest act of the vaginal mesh litigation drama, plaintiffs' lawyers disputed J&J's claims that fishy phone calls recruiting women to file vaginal mesh-related suits are tainting the legal process and deserve further investigation.

Medical devices weigh on J&J; focuses on innovation, hospital bundling to improve

Johnson & Johnson is working to make its medical device business grow as fast as the pharmaceutical side--but for now devices sales growth is slowing, while pharma is picking up fast. 

MORE NEWS

From Our Sister Sites

FierceAnimalHealth

Merck is financing a $1.85 million study being conducted at Texas Tech University to see if lower dosages of its lucrative but controversial cattle growth drug Zilmax could allow the company to reintroduce the product to U.S. and global markets and kick-start sales.

FierceAnimalHealth

A survey of 2,000 pet owners conducted by Bayer HealthCare Animal Health and the Companion Animal Parasite Council has revealed that when veterinarians provide information to clients about parasites prevalent in their area, they can drive up clinic visits.